19-10317588-C-T

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_133452.3(RAVER1):​c.2086G>A​(p.Gly696Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0000547 in 1,609,268 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.00017 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000043 ( 0 hom. )

Consequence

RAVER1
NM_133452.3 missense

Scores

6
11

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 4.78
Variant links:
Genes affected
RAVER1 (HGNC:30296): (ribonucleoprotein, PTB binding 1) Enables RNA binding activity. Predicted to be involved in regulation of alternative mRNA splicing, via spliceosome. Predicted to be located in cytoplasm. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.05695957).
BS2
High AC in GnomAd4 at 26 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
RAVER1NM_133452.3 linkuse as main transcriptc.2086G>A p.Gly696Ser missense_variant 13/13 ENST00000617231.5 NP_597709.3 Q8IY67
RAVER1NM_001366174.1 linkuse as main transcriptc.2011G>A p.Gly671Ser missense_variant 14/14 NP_001353103.1
RAVER1XM_047438143.1 linkuse as main transcriptc.1069G>A p.Gly357Ser missense_variant 9/9 XP_047294099.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
RAVER1ENST00000617231.5 linkuse as main transcriptc.2086G>A p.Gly696Ser missense_variant 13/135 NM_133452.3 ENSP00000482277.1 A0A087WZ13
ENSG00000267303ENST00000586529.1 linkuse as main transcriptn.340G>A non_coding_transcript_exon_variant 5/85 ENSP00000467814.1 K7EQG2
RAVER1ENST00000592208.5 linkuse as main transcriptn.3320G>A non_coding_transcript_exon_variant 10/101

Frequencies

GnomAD3 genomes
AF:
0.000171
AC:
26
AN:
152080
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00118
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.000957
GnomAD3 exomes
AF:
0.0000919
AC:
22
AN:
239480
Hom.:
0
AF XY:
0.0000763
AC XY:
10
AN XY:
131098
show subpopulations
Gnomad AFR exome
AF:
0.0000680
Gnomad AMR exome
AF:
0.000449
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000567
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000468
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000425
AC:
62
AN:
1457188
Hom.:
0
Cov.:
32
AF XY:
0.0000345
AC XY:
25
AN XY:
724902
show subpopulations
Gnomad4 AFR exome
AF:
0.0000600
Gnomad4 AMR exome
AF:
0.000341
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000504
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000324
Gnomad4 OTH exome
AF:
0.000116
GnomAD4 genome
AF:
0.000171
AC:
26
AN:
152080
Hom.:
0
Cov.:
32
AF XY:
0.000215
AC XY:
16
AN XY:
74306
show subpopulations
Gnomad4 AFR
AF:
0.0000483
Gnomad4 AMR
AF:
0.00118
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000588
Gnomad4 OTH
AF:
0.000957
Alfa
AF:
0.0000451
Hom.:
0
Bravo
AF:
0.000166
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000122
AC:
1
ExAC
AF:
0.0000581
AC:
7

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsNov 25, 2024The c.2137G>A (p.G713S) alteration is located in exon 13 (coding exon 13) of the RAVER1 gene. This alteration results from a G to A substitution at nucleotide position 2137, causing the glycine (G) at amino acid position 713 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.40
T
BayesDel_noAF
Benign
-0.49
CADD
Pathogenic
28
DANN
Uncertain
1.0
DEOGEN2
Benign
0.010
.;T;T
Eigen
Uncertain
0.32
Eigen_PC
Uncertain
0.40
FATHMM_MKL
Uncertain
0.87
D
LIST_S2
Uncertain
0.88
D;.;D
M_CAP
Benign
0.0065
T
MetaRNN
Benign
0.057
T;T;T
MetaSVM
Benign
-0.98
T
PrimateAI
Uncertain
0.60
T
PROVEAN
Benign
0.25
.;N;.
REVEL
Benign
0.14
Sift
Benign
0.46
.;T;.
Sift4G
Benign
0.47
T;T;T
Polyphen
0.96
.;D;D
Vest4
0.11
MVP
0.21
MPC
0.35
ClinPred
0.11
T
GERP RS
5.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
gMVP
0.52

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs375929079; hg19: chr19-10428264; API